AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 296: H195-H201, 2009. First published November 14, 2008; doi:10.1152/ajpheart.00679.2008
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/1/H195    most recent
00679.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kida, T.
Right arrow Articles by Ozaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kida, T.
Right arrow Articles by Ozaki, H.

Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle

Taiki Kida, Takahisa Murata, Masatoshi Hori, and Hiroshi Ozaki

Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan

Submitted 30 June 2008 ; accepted in final form 6 November 2008

Farnesoid X receptor (FXR), a member of the nuclear receptor superfamily that is highly expressed in enterohepatic tissue, is implicated in bile acid, lipid, and glucose metabolisms. Although recent studies showed that FXR is also expressed in vascular endothelial cells and smooth muscle cells, its physiological and/or pathological roles in vasculature tissue remain unknown. The aim of this study is to examine the chronic effect of synthetic FXR agonist GW4064 on vascular contraction and endothelium-dependent relaxation using tissue culture procedure. In cultured rabbit mesenteric arteries, the treatment with 0.1–10 µM GW4064 for 7 days did not influence vascular contractility induced by high K+ (15–65 mM), norepinephrine (0.1–100 µM), and endothelin-1 (0.1–100 nM). However, the chronic treatment with GW4064 (1–10 µM for 7 days) dose dependently impaired endothelium-dependent relaxation induced by substance P (0.1–30 nM). In hematoxylin-eosin cross sectioning and en face immunostaining, GW4064 had no effects on the morphology of endothelial and smooth muscle cells. In endothelium-denuded arteries treated with GW4064 (1–10 µM) for 7 days, 3 nM–100 µM sodium nitroprusside-induced vasorelaxation, but not membrane-permeable cGMP analog 8-bromoguanosine-cGMP (8-Br-cGMP; 1–100 µM)-induced vasorelaxation, was significantly impaired. In these GW4064-treated arteries, 1 µM sodium nitroprusside-induced intracellular cGMP elevations were impaired. In RT-PCR, any changes were detected in mRNA expression level of {alpha}1- and β1-subunit of soluble guanylyl cyclase. These results suggest that chronic stimulation of FXR impairs endothelium-dependent relaxation, which is due to decreased sensitivity of smooth muscle cells to nitric oxide.

nuclear receptor; guanosine 3',5'-cyclic monophosphate; endothelium-dependent relaxation; GW4064; rabbit mesenteric artery



Address for reprint requests and other correspondence: T. Murata, Dept. of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The Univ. of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan (e-mail: murata{at}mail.vm.a.u-tokyo.ac.jp)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.